Interestingly, the Bacillus Calmette–Guerin vaccine is approved for the treatment of bladder cancer [35], where stimulation of TLR2 and TLR4 are responsible for the observed anti-cancer effect. This evidence concerns the gene TLR4 and urinary bladder cancer.